Table 3. The association between body composition and testosterone (ng/dL) of participants with BMI ≥ 30.
Model 1 | Model 2 | Model 3 | |
---|---|---|---|
β (95% CI) P value | β (95% CI) P value | β (95% CI) P value | |
Total | |||
TPF (%) | -16.88 (-17.79, -15.97) <0.001 | -5.57 (-6.70, -4.44) <0.001 | -5.32 (-6.47, -4.16) <0.001 |
APF (%) | -14.51 (-15.65, -13.37) <0.001 | -5.04 (-6.03, -4.04) <0.001 | -4.82 (-5.83, -3.80) <0.001 |
GPF (%) | -14.80 (-15.68, -13.92) <0.001 | -2.88 (-3.99, -1.77) <0.001 | -2.86 (-3.98, -1.73) <0.001 |
A/G | 355.57 (305.74, 405.40) <0.001 | -123.59 (-165.31, -81.87) <0.001 | -111.92 (-154.41, -69.43) <0.001 |
LMP (%) | 17.56 (16.62, 18.50) <0.001 | 5.63 (4.44, 6.82) <0.001 | 5.37 (4.15, 6.58) <0.001 |
Sex | |||
Males | |||
TPF (%) | -6.74 (-8.19, -5.29) <0.001 | -6.80 (-8.26, -5.33) <0.001 | -6.54 (-8.04, -5.04) <0.001 |
APF (%) | -6.27 (-7.56, -4.98) <0.001 | -6.29 (-7.59, -4.99) <0.001 | -6.07 (-7.39, -4.74) <0.001 |
GPF (%) | -3.40 (-4.84, -1.96) <0.001 | -3.61 (-5.09, -2.14) <0.001 | -3.61 (-5.10, -2.12) <0.001 |
A/G | -143.20 (-194.59, -91.81) <0.001 | -147.85 (-201.21, -94.48) <0.001 | -131.90 (-186.31, -77.48) <0.001 |
LMP (%) | 6.81 (5.28, 8.34) <0.001 | 6.87 (5.32, 8.41) <0.001 | 6.59 (5.01, 8.17) <0.001 |
Females | |||
TPF (%) | 0.07 (-0.29, 0.43) 0.72 | 0.14 (-0.22, 0.49) 0.46 | 0.19 (-0.18, 0.56) 0.31 |
APF (%) | 0.19 (-0.11, 0.49) 0.220 | 0.18 (-0.12, 0.48) 0.24 | 0.21 (-0.10, 0.51) 0.18 |
GPF (%) | 0.03 (-0.29, 0.36) 0.85 | -0.02 (-0.34, 0.31) 0.92 | 0.05 (-0.28, 0.38) 0.7736 |
A/G | 10.39 (-4.31, 25.08) 0.17 | 13.01 (-1.47, 27.48) 0.08 | 12.00 (-3.02, 27.01) 0.12 |
LMP (%) | -0.06 (-0.44, 0.32) 0.77 | -0.12 (-0.50, 0.26) 0.53 | -0.18 (-0.57, 0.21) 0.36 |
Notes: No covariate was adjusted in Model 1. Model 2 indicates that analysis was adjusted for age, sex, and race. Model 3 indicates model 2 adjustment plus the adjustment for hypertension, diabetes, hypercholesteremia, smoking status, vigorous work activity.
Sex was not adjusted in the sex-stratified subgroup analyses.